ArticleHuman genomics2026
Single-cell and machine learning-integrated bulk RNA-seq analysis reveals TKT as an oxidative stress-associated diagnostic biomarker in acute myocardial infarction.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute myocardial infarction (AMI) is a leading cause of death worldwide, with oxidative stress (OS) playing a central role in its pathogenesis. However, the dynamic expression profiles and functional implications of OS-related genes at the single-cell level remain poorly understood.
methodsOS activity first assessed in single-cell RNA sequencing (scRNA-seq) data from myocardial tissue samples. Then, we integrated scRNA-seq data from AMI patients with multi-cohort bulk RNA-seq datasets to comprehensively assess OS activity across peripheral immune cells. A curated list of 807 OS-related genes was used to construct OS activity scores at the single-cell level. Differential analysis, correlation filtering, and univariate logistic regression were applied to identify high-risk OS-related genes. Six machine learning algorithms-including LASSO, Random Forest, Boruta, Bayesian modeling, LVQ, and Treebag were used in consensus to prioritize diagnostic biomarkers. To further characterize the functional implications of TKT, we performed downstream analyses including Western Blot analysis, single-cell expression profiling, pseudotime trajectory inference, and cell-cell communication network construction.
resultsTKT emerged as a robust diagnostic marker, consistently selected across all machine learning models and validated in both training and independent cohorts (AUC > 0.73). TKT was predominantly expressed in monocytes and neutrophils theoretically, where it correlated with high OS activity and pro-inflammatory gene signatures. Pseudotime analysis revealed distinct expression dynamics in monocyte and neutrophil lineages. CellChat analysis further suggested that TKT⁺ immune cells act as central hubs within the AMI immune microenvironment, mediating enhanced inflammatory communication.
conclusionThis study identifies TKT as a high-confidence, oxidative stress-associated biomarker for AMI through an integrated multi-omics and machine learning approach. TKT may serve as a bridge between metabolic reprogramming and immune activation, offering insights into potential therapeutic targets in post-infarction inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.